Aarti Pharmalabs Ltd (AARP)

Currency in INR
855.50
-23.55(-2.68%)
Closed·
AARTIPHARM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
850.00892.00
52 wk Range
585.001,002.40
Key Statistics
Bid/Ask
856.00 / 858.95
Prev. Close
855.5
Open
880.7
Day's Range
850-892
52 wk Range
585-1,002.4
Volume
444.38K
Average Volume (3m)
806.55K
1-Year Change
2.8987%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AARTIPHARM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
740.00
Downside
-13.50%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 740.00
(-13.50% Downside)

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
8.39 / --
Revenue / Forecast
5.36B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 22.56%
Dividend Yield
0.41%
Industry Median 0.65%
Annualised payout
3.50
Paid unevenly
5-Years Growth
-
Growth Streak

AARTIPHARM Income Statement

Compare AARTIPHARM to Peers and Sector

Metrics to compare
AARTIPHARM
Peers
Sector
Relationship
P/E Ratio
37.9x34.3x−0.3x
PEG Ratio
−1.630.530.00
Price/Book
3.7x3.2x2.6x
Price / LTM Sales
3.9x3.5x3.0x
Upside (Analyst Target)
−13.5%17.5%61.2%
Fair Value Upside
Unlock−0.3%7.2%Unlock

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates, such as xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. It serves pharmaceutical, nutraceutical, and beverage industries. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Employees
2421
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.86M5.36%4.16B
Other Institutional Investors
24.44M26.96%20.91B
Public Companies & Retail Investors
61.37M67.68%52.50B
Total
90.68M100.00%77.58B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Life Insurance Corporation of India5.27%4,782,4524,091,388
Anushakti Enterprise Private Limited3.30%2,992,9502,560,469

People Also Watch

592.70
GNFC
-1.09%
2,640.40
WGSR
-0.41%
1,636.00
PAYT
-0.34%
309.10
MARK
+0.42%

FAQ

What Is the Aarti Pharmalabs (AARTIPHARM) Stock Price Today?

The Aarti Pharmalabs stock price today is 855.50 INR.

What Stock Exchange Does Aarti Pharmalabs Trade On?

Aarti Pharmalabs is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Aarti Pharmalabs?

The stock symbol for Aarti Pharmalabs is "AARTIPHARM."

What Is the Aarti Pharmalabs Market Cap?

As of today, Aarti Pharmalabs market cap is 77.58B INR.

What Is Aarti Pharmalabs's Earnings Per Share (TTM)?

The Aarti Pharmalabs EPS (TTM) is 22.56.

From a Technical Analysis Perspective, Is AARTIPHARM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Aarti Pharmalabs Stock Split?

Aarti Pharmalabs has split 0 times.

How Many Employees Does Aarti Pharmalabs Have?

Aarti Pharmalabs has 2421 employees.

What is the current trading status of Aarti Pharmalabs (AARTIPHARM)?

As of Oct 11, 2026, Aarti Pharmalabs (AARTIPHARM) is trading at a price of 855.50 INR, with a previous close of 855.50 INR. The stock has fluctuated within a day range of 850.00 INR to 892.00 INR, while its 52-week range spans from 585.00 INR to 1,002.40 INR.

What Is Aarti Pharmalabs (AARTIPHARM) Price Target According to Analysts?

The average 12-month price target for Aarti Pharmalabs is 740.00 INR, with a high estimate of 740 INR and a low estimate of 740 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -13.50% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.